The minimally important difference for the Xerostomia Inventory among Sjögren's disease patients.

Autor: Assy Z; Department of Oral Biochemistry, Academic Centre for Dentistry Amsterdam, University of Amsterdam and VU University Amsterdam, Amsterdam, The Netherlands., Thomson WM; Sir John Walsh Research Institute, University of Otago Faculty of Dentistry, Dunedin, New Zealand., Brand HS; Department of Oral Biochemistry, Academic Centre for Dentistry Amsterdam, University of Amsterdam and VU University Amsterdam, Amsterdam, The Netherlands., Cha S; Department of Oral and Maxillofacial Diagnostic Sciences, Center for Orphaned Autoimmune Disorders, University of Florida, Gainesville, Florida, USA., Susam MM; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Weisman GA; Department of Biochemistry, Christopher S. Bond Life Sciences Center, University of Missouri, Columbia, Missouri, USA., Vissink A; Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Bikker FJ; Department of Oral Biochemistry, Academic Centre for Dentistry Amsterdam, University of Amsterdam and VU University Amsterdam, Amsterdam, The Netherlands., Jager DHJ; Department of Oral and Maxillofacial Surgery/Oral Pathology, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Inflammatory Diseases, Amsterdam, The Netherlands.

Publikováno v: Oral diseases [Oral Dis] 2024 Oct; Vol. 30 (7), pp. 4356-4363. Date of Electronic Publication: 2023 Dec 26.

Bioanalytical assay for the quantification of the tyrosine kinase inhibitor EAI045 and its major metabolite PIA in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry.

Autor: Susam MM; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, CX, Amsterdam, The Netherlands.; Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, CG, Utrecht, The Netherlands., Wang J; Division of Pharmacology, The Netherlands Cancer Institute, CX, Amsterdam, The Netherlands., Schinkel AH; Division of Pharmacology, The Netherlands Cancer Institute, CX, Amsterdam, The Netherlands., Beijnen JH; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, CX, Amsterdam, The Netherlands.; Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, CG, Utrecht, The Netherlands.; Division of Pharmacology, The Netherlands Cancer Institute, CX, Amsterdam, The Netherlands., Sparidans RW; Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacology, Utrecht University, CG, Utrecht, the Netherlands.

Publikováno v: Biomedical chromatography : BMC [Biomed Chromatogr] 2022 Nov; Vol. 36 (11), pp. e5457. Date of Electronic Publication: 2022 Aug 01.